Increased serum TSH can then act on TSH receptors in adipocytes to inhibit adipose triglyceride lipase, which in turn causes increased storage of triglycerides and an increase in adipocyte size, ultimately leading to overweight or obesity (29). Here, DDHD2 is linked to obesity due to melanocortin 4 receptor deficiency.